ArticleIndian journal of ophthalmology2026
One-year rotational stability and refractive outcomes of the Acriva BB T UDM 611 toric ıntraocular lens: A prospective study.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the 1-year clinical outcomes of the Acriva BB T UDM 611 toric intraocular lens (IOL) following cataract surgery in patients with preoperative corneal astigmatism, focusing on rotational stability, refractive efficacy, visual acuity, contrast sensitivity (CS), and safety.
methodsThis prospective longitudinal study included 39 eyes of 32 patients with age-related cataract and regular corneal astigmatism ≥1.0 diopter who underwent phacoemulsification and toric IOL implantation at a tertiary eye care center. Preoperative and postoperative assessments included uncorrected (UDVA) and corrected distance visual acuity (CDVA), corneal and refractive astigmatism, IOL rotation, decentration, and tilt. The CSV-1000 test was used to measure CS at 2.5 m under photopic, mesopic, and mesopic with glare conditions. Adverse events were recorded.
resultsThe mean logMAR UDVA improved significantly from 0.95± 0.39 preoperatively to 0.06 ± 0.10 at 1 year (p < 0.001). The refractive cylinder decreased from -2.17 ± 1.75 D to -0.21 ± 0.32 D (p < 0.001). The mean IOL rotation was 1.61° ±2.35°, with 89.7% of eyes within ±5° and all within ±10° of the intended axis. No IOL repositioning was required. No patients reported disturbing visual phenomena, and no vision-threatening complications occurred during the follow-up.
conclusionsThe Acriva BB T UDM 611 toric IOL demonstrated excellent rotational stability, significant refractive accuracy, and favorable safety and CS outcomes at 1 year postoperatively. These results support its efficacy in correcting pre-existing corneal astigmatism in cataract patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.